A FAMILY HISTORY OF HYPERTENSION IS ASSOC IATED WITH THE DEVELOPMENT OF HYPERTENSION AND NEPHROANGIOSCLEROSIS IN PATIENTS WITH GLOMERULONEPHRITIS DUE TO MESANGIAL IGA DEPOSITS
R. Boulahrouz et al., A FAMILY HISTORY OF HYPERTENSION IS ASSOC IATED WITH THE DEVELOPMENT OF HYPERTENSION AND NEPHROANGIOSCLEROSIS IN PATIENTS WITH GLOMERULONEPHRITIS DUE TO MESANGIAL IGA DEPOSITS, Archives des maladies du coeur et des vaisseaux, 89(8), 1996, pp. 1065-1068
The progress of IgA Nephropathy (IgAN) is correlated with glomerular a
nd vascular sclerosis. Renal vascular lesions, i.e. nephrosclerosis, o
ften precede the onset of hypertension (HBP) in young patients with Ig
AN. It is also recognized that a family history of HBP (FHBP) is stron
gly predictive of future onset of HBP in family members, when two or m
ore first-degree relatives with HBP are identified. In order to examin
e the possible link between FHBP and nephrosclerosis, we compared 2 gr
oups of 29 pts each (23 M and 6 F) with IgAN, matched for age and sex,
according to the presence or absence of FHBP. FHBP was considered pre
sent if at least 2 or more Ist degree relatives under 60 years of age
received antihypertensive Rx. Parents and siblings of patients were ex
amined at home by tow investigators. Patients with FHBP (+) and FHBP (
-) were aged 36+/-12 and 35+/-12, respectively, at the time of renal b
iopsy and the follow-up was conducted for an average of 4.6 years. At
the end of this survey, HBP and renal failure (Cr Cl <80 ml/min) were
reevaluated in all patients. At the time of renal biopsy, nephrosclero
sis was significantly associated with FHBP: FHBP(+):96.5% versus FHBP(
-):10.3%; p <0.0001. At the end of the follow-up, FHBP was found to be
associated with HBP (89.6% versus 10.3%; p <0.0001) and with renal fa
ilure (44.8% versus 3.4%; p <0.001). These data suggest that nephroscl
erosis has a strong genetic component in patients with IgAN, FHBP is a
n early clinical indicator of nephrosclerosis in these patients and th
at FHBP is a strong indicator of unfavorable prognosis in IgAN.